Brief: Cytocom Q2 Loss Per Share Of $0.04
Aug 16 (Reuters) - Cytocom Inc CBLI.O :
* Q2 LOSS PER SHARE $0.04
* EXPECTS ITS CASH POSITION TO INCREASE TO $30 MILLION BY
END OF
AUGUST 2021
* BELIEVES CASH POSITION, OTHER CAPITAL SOURCES ARE
SUFFICIENT TO
FUND CONTINUED ADVANCEMENT OF CLINICAL-STAGE PIPELINE
Source text for Eikon: [https://bit.ly/2UraqiA]
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc